Related Experiment Video

Updated: Feb 7, 2026

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

1.2K

[miRNA as a bullet against cystic fibrosis]

Pauline Bardin1, Florence Sonneville1, Olivier Tabary1

  • 1Sorbonne Université, UMR-S938, Centre de recherche Saint-Antoine (CRSA), Hôpital Saint-Antoine, 34, rue Crozatier, 75012 Paris, France.

Medecine Sciences : M/S
|August 2, 2018
PubMed

Insights

Cystic fibrosis (CF), a lethal genetic disease caused by CFTR gene mutations, lacks curative treatments. MicroRNAs (miRNAs) show therapeutic potential by regulating gene expression involved in CF pathology, offering new treatment avenues.

Area of Science:

  • Genetics and Molecular Biology
  • Pulmonology
  • Pharmacology

Background:

  • Cystic fibrosis (CF) is a prevalent lethal genetic disorder in Caucasians, caused by mutations in the CFTR gene encoding a chloride channel.
  • Despite the CFTR gene discovery in 1989, effective curative therapies for CF patients remain limited.
  • Emerging therapeutic strategies are investigating microRNAs (miRNAs) for their role in regulating target mRNA expression.

Purpose of the Study:

  • To review the involvement of miRNAs in the pathogenesis of cystic fibrosis.
  • To explore the therapeutic potential of targeting miRNAs in CF.
  • To highlight miRNA roles in ion channel control, inflammation, infection, and bronchial obstruction in CF.

Main Methods:

  • Literature review of scientific publications on cystic fibrosis and microRNAs.
  • Analysis of studies investigating miRNA involvement in CF-related biological processes.
  • Synthesis of current research on miRNA-based therapeutic strategies for CF.

Main Results:

  • MicroRNAs play a significant role in regulating key aspects of cystic fibrosis pathology.
  • Specific miRNAs are implicated in controlling ion channel function, modulating inflammation, and influencing infection susceptibility in CF.
  • Dysregulated miRNA expression contributes to bronchial obstruction observed in CF patients.

Conclusions:

  • MicroRNAs represent a promising therapeutic target for cystic fibrosis.
  • Targeting miRNAs could offer novel strategies to manage CF symptoms and progression.
  • Further research into miRNA mechanisms and therapeutic delivery is warranted for CF treatment development.

More Related Videos

Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis07:56

Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis

Published on: June 10, 2022

3.3K
Expression and Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein in Saccharomyces cerevisiae14:56

Expression and Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein in Saccharomyces cerevisiae

Published on: March 10, 2012

19.1K

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
888
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
545
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.2K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.7K
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.4K